Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs116404973 | chr1:227389640 | A/G | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11642262 | chr16:85362809 | T/C | 2.0E-6 | 174 | 3.43 | 15.67 | 15.48 | KM Plot |
| PAAD | rs116497055 | chr8:72582675 | C/T | 5.26E-8 | 174 | 15.87 | 13.1 | 3.17 | KM Plot |
| PAAD | rs11657453 | chr17:6070167 | T/C | 1.32E-12 | 174 | 15.37 | 16.17 | 1.37 | KM Plot |
| PAAD | rs116588679 | chr1:227535745 | C/T | 1.03E-5 | 175 | 15.55 | 15.65 | 3.9 | KM Plot |
| PAAD | rs116628261 | chr1:227555669 | A/G | 1.78E-5 | 175 | 15.4 | 17.03 | 3.9 | KM Plot |
| PAAD | rs116647640 | chr1:227408696 | A/G | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs116657151 | chr1:227530925 | A/G | 1.03E-5 | 175 | 15.55 | 15.65 | 3.9 | KM Plot |
| PAAD | rs116691311 | chr1:16817376 | C/T | 3.16E-5 | 170 | 15.4 | 16.03 | 4.62 | KM Plot |
| PAAD | rs11672352 | chr19:41548090 | A/G | 6.91E-5 | 171 | 16.48 | 14.6 | 8.23 | KM Plot |
| PAAD | rs116732179 | chr1:227526671 | A/G | 9.04E-6 | 176 | 15.57 | 15.65 | 3.9 | KM Plot |
| PAAD | rs11678032 | chr2:128576409 | G/T | 7.86E-10 | 178 | 15.72 | 12.5 | 2.2 | KM Plot |
| PAAD | rs116805426 | chr1:227394024 | T/C | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs11682274 | chr2:128495905 | C/T | 1.18E-9 | 175 | 15.67 | 12.5 | 2.2 | KM Plot |
| PAAD | rs116838175 | chr1:227442373 | C/T | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |